PD-L1 mRNA Baseline Expression May Indicate Response to Atezolizumab Plus Nab-paclitaxel in TNBC

The patterns of PD-L1 mRNA expression in plasma-derived exosomes at baseline corresponded to response to atezolizumab plus nab-paclitaxel and survival in patients with triple negative breast cancer